{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:49:59Z","timestamp":1768585799302,"version":"3.49.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12016-019-08745-w","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T22:02:13Z","timestamp":1559772133000},"page":"375-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmunity in 2018"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-0376","authenticated-orcid":false,"given":"Carlo","family":"Selmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"8745_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt A, Chiricozzi A (2018) The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol 55:379\u2013390","journal-title":"Clin Rev Allergy Immunol"},{"key":"8745_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","volume":"96","author":"L Chakievska","year":"2019","unstructured":"Chakievska L, Holtsche MM, Kunstner A, Goletz S, Petersen BS, Thaci D et al (2019) IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. J Autoimmun 96:104\u2013112","journal-title":"J Autoimmun"},{"key":"8745_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","volume":"54","author":"C Conrad","year":"2018","unstructured":"Conrad C, Gilliet M (2018) Psoriasis: from pathogenesis to targeted therapies. Clin Rev Allergy Immunol 54:102\u2013113","journal-title":"Clin Rev Allergy Immunol"},{"key":"8745_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","volume":"19","author":"T Dainichi","year":"2018","unstructured":"Dainichi T, Kitoh A, Otsuka A, Nakajima S, Nomura T, Kaplan DH, Kabashima K (2018) The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis. Nat Immunol 19:1286\u20131298","journal-title":"Nat Immunol"},{"key":"8745_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.autrev.2018.08.006","volume":"18","author":"S Dolff","year":"2019","unstructured":"Dolff S, Witzke O, Wilde B (2019) Th17 cells in renal inflammation and autoimmunity. Autoimmun Rev 18:129\u2013136","journal-title":"Autoimmun Rev"},{"key":"8745_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.autrev.2018.04.002","volume":"17","author":"E Generali","year":"2018","unstructured":"Generali E, Bose T, Selmi C, Voncken JW, Damoiseaux J (2018) Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory. Autoimmun Rev 17:935\u2013941","journal-title":"Autoimmun Rev"},{"key":"8745_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4049\/jimmunol.1701157","volume":"201","author":"Y Hashiguchi","year":"2018","unstructured":"Hashiguchi Y, Yabe R, Chung SH, Murayama MA, Yoshida K, Matsuo K, Kubo S, Saijo S, Nakamura Y, Matsue H, Iwakura Y (2018) IL-36alpha from skin-resident cells plays an important role in the pathogenesis of imiquimod-induced psoriasiform dermatitis by forming a local autoamplification loop. J Immunol 201:167\u2013182","journal-title":"J Immunol"},{"key":"8745_CR8","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG (2018) Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol 201:1605\u20131613","journal-title":"J Immunol"},{"key":"8745_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jaut.2018.01.001","volume":"87","author":"AM McGinley","year":"2018","unstructured":"McGinley AM, Edwards SC, Raverdeau M, Mills KHG (2018) Th17cells, gammadelta T cells and their interplay in EAE and multiple sclerosis. J Autoimmun 87:97\u2013108","journal-title":"J Autoimmun"},{"key":"8745_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.4049\/jimmunol.1700507","volume":"201","author":"RJ Napier","year":"2018","unstructured":"Napier RJ, Lee EJ, Vance EE, Snow PE, Samson KA, Dawson CE et al (2018) Nod2 deficiency augments Th17 responses and exacerbates autoimmune arthritis. J Immunol 201:1889\u20131898","journal-title":"J Immunol"},{"key":"8745_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4049\/jimmunol.1800636","volume":"202","author":"C Skon-Hegg","year":"2019","unstructured":"Skon-Hegg C, Zhang J, Wu X, Sagolla M, Ota N, Wuster A, Tom J, Doran E, Ramamoorthi N, Caplazi P, Monroe J, Lee WP, Behrens TW (2019) LACC1 regulates TNF and IL-17 in mouse models of arthritis and inflammation. J Immunol 202:183\u2013193","journal-title":"J Immunol"},{"key":"8745_CR12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4049\/jimmunol.1700596","volume":"200","author":"A Soare","year":"2018","unstructured":"Soare A, Weber S, Maul L, Rauber S, Gheorghiu AM, Luber M, Houssni I, Kleyer A, von Pickardt G, Gado M, Simon D, Rech J, Schett G, Distler JHW, Ramming A (2018) Cutting edge: homeostasis of innate lymphoid cells is imbalanced in psoriatic arthritis. J Immunol 200:1249\u20131254","journal-title":"J Immunol"},{"key":"8745_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.autrev.2017.11.037","volume":"17","author":"Y Segal","year":"2018","unstructured":"Segal Y, Dahan S, Sharif K, Bragazzi NL, Watad A, Amital H (2018) The value of autoimmune syndrome induced by adjuvant (ASIA) - shedding light on orphan diseases in autoimmunity. Autoimmun Rev 17:440\u2013448","journal-title":"Autoimmun Rev"},{"key":"8745_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.autrev.2018.01.017","volume":"17","author":"LC Su","year":"2018","unstructured":"Su LC, Liu XY, Huang AF, Xu WD (2018) Emerging role of IL-35 in inflammatory autoimmune diseases. Autoimmun Rev 17:665\u2013673","journal-title":"Autoimmun Rev"},{"key":"8745_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2017.12.003","volume":"87","author":"T Agalioti","year":"2018","unstructured":"Agalioti T, Villablanca EJ, Huber S, Gagliani N (2018) TH17cell plasticity: the role of dendritic cells and molecular mechanisms. J Autoimmun 87:50\u201360","journal-title":"J Autoimmun"},{"key":"8745_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2018.05.005","volume":"92","author":"J Nowatzky","year":"2018","unstructured":"Nowatzky J, Manches O, Khan SA, Godefroy E, Bhardwaj N (2018) Modulation of human Th17 cell responses through complement receptor 3 (CD11b\/CD18) ligation on monocyte-derived dendritic cells. J Autoimmun 92:57\u201366","journal-title":"J Autoimmun"},{"key":"8745_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2018.10.022","volume":"95","author":"R Taubert","year":"2018","unstructured":"Taubert R, Hupa-Breier KL, Jaeckel E, Manns MP (2018) Novel therapeutic targets in autoimmune hepatitis. J Autoimmun 95:34\u201346","journal-title":"J Autoimmun"},{"key":"8745_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2017.12.004","volume":"87","author":"A Ueno","year":"2018","unstructured":"Ueno A, Jeffery L, Kobayashi T, Hibi T, Ghosh S, Jijon H (2018) Th17 plasticity and its relevance to inflammatory bowel disease. J Autoimmun 87:38\u201349","journal-title":"J Autoimmun"},{"key":"8745_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaut.2018.01.007","volume":"90","author":"X Jiang","year":"2018","unstructured":"Jiang X, Lian M, Li Y, Zhang W, Wang Q, Wei Y, Zhang J, Chen W, Xiao X, Miao Q, Bian Z, Qiu D, Fang J, Ansari AA, Leung PSC, Coppel RL, Tang R, Gershwin ME, Ma X (2018) The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: regulation by cholic acid-induced Interleukin-7. J Autoimmun 90:64\u201375","journal-title":"J Autoimmun"},{"key":"8745_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2018.04.003","volume":"91","author":"E Cretney","year":"2018","unstructured":"Cretney E, Leung PS, Trezise S, Newman DM, Rankin LC, Teh CE et al (2018) Characterization of Blimp-1 function in effector regulatory T cells. J Autoimmun 91:73\u201382","journal-title":"J Autoimmun"},{"key":"8745_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaut.2018.09.009","volume":"95","author":"YH Hsueh","year":"2018","unstructured":"Hsueh YH, Chen HW, Syu BJ, Lin CI, Leung PSC, Gershwin ME, Chuang YH (2018) Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis. J Autoimmun 95:159\u2013170","journal-title":"J Autoimmun"},{"key":"8745_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaut.2017.12.011","volume":"89","author":"Y Yao","year":"2018","unstructured":"Yao Y, Li L, Yang SH, Gao CY, Liao LH, Xie YQ, Yin XY, Yang YQ, Fei YY, Lian ZX (2018) CD8(+) T cells and IFN-gamma induce autoimmune myelofibrosis in mice. J Autoimmun 89:101\u2013111","journal-title":"J Autoimmun"},{"key":"8745_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jaut.2018.08.003","volume":"94","author":"A Lombardi","year":"2018","unstructured":"Lombardi A, Tsomos E, Hammerstad SS, Tomer Y (2018) Interferon alpha: the key trigger of type 1 diabetes. J Autoimmun 94:7\u201315","journal-title":"J Autoimmun"},{"key":"8745_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jaut.2018.12.004","volume":"98","author":"T Nii","year":"2019","unstructured":"Nii T, Kuzuya K, Kabata D, Matsui T, Murata A, Ohya T, Matsuoka H, Shimizu T, Oguro E, Okita Y, Udagawa C, Yoshimura M, Kudo-Tanaka E, Teshigawara S, Harada Y, Yoshida Y, Isoda K, Tsuji SI, Ohshima S, Hashimoto J, Shintani A, Takehana Y, Tohma S, Saeki Y (2019) Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor -kappa B activation: a possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smoking. J Autoimmun 98:95\u2013102","journal-title":"J Autoimmun"},{"key":"8745_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaut.2018.06.001","volume":"93","author":"Y Zhen","year":"2018","unstructured":"Zhen Y, Lee IJ, Finkelman FD, Shao WH (2018) Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis. J Autoimmun 93:37\u201344","journal-title":"J Autoimmun"},{"key":"8745_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2018.05.004","volume":"92","author":"Q Wang","year":"2018","unstructured":"Wang Q, Wang C, Li N, Liu X, Ren W, Wang Q, Cao X (2018) Condensin Smc4 promotes inflammatory innate immune response by epigenetically enhancing NEMO transcription. J Autoimmun 92:67\u201376","journal-title":"J Autoimmun"},{"key":"8745_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2018.10.005","volume":"97","author":"P Lamprecht","year":"2019","unstructured":"Lamprecht P, Fischer N, Huang J, Burkhardt L, Lutgehetmann M, Arndt F et al (2019) Changes in the composition of the upper respiratory tract microbial community in granulomatosis with polyangiitis. J Autoimmun 97:29\u201339","journal-title":"J Autoimmun"},{"key":"8745_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2018.06.004","volume":"93","author":"M Zaheer","year":"2018","unstructured":"Zaheer M, Wang C, Bian F, Yu Z, Hernandez H, de Souza RG, Simmons KT, Schady D, Swennes AG, Pflugfelder SC, Britton RA, de Paiva CS (2018) Protective role of commensal bacteria in Sjogren syndrome. J Autoimmun 93:45\u201356","journal-title":"J Autoimmun"},{"key":"8745_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2018.06.003","volume":"93","author":"E Gulden","year":"2018","unstructured":"Gulden E, Chao C, Tai N, Pearson JA, Peng J, Majewska-Szczepanik M et al (2018) TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells. J Autoimmun 93:57\u201365","journal-title":"J Autoimmun"},{"key":"8745_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.07.003","volume":"93","author":"C Huang","year":"2018","unstructured":"Huang C, Wang J, Zheng X, Chen Y, Zhou R, Wei H, Sun R, Tian Z (2018) Commensal bacteria aggravate allergic asthma via NLRP3\/IL-1beta signaling in post-weaning mice. J Autoimmun 93:104\u2013113","journal-title":"J Autoimmun"},{"key":"8745_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.10.009","volume":"97","author":"TA van der Meulen","year":"2019","unstructured":"van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A, Fu J, Wijmenga C, Weersma RK, de Leeuw K, Bootsma H, Spijkervet FKL, Vissink A, Kroese FGM (2019) Shared gut, but distinct oral microbiota composition in primary Sjogren\u2019s syndrome and systemic lupus erythematosus. J Autoimmun 97:77\u201387","journal-title":"J Autoimmun"},{"key":"8745_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jaut.2018.10.015","volume":"95","author":"A Gerussi","year":"2018","unstructured":"Gerussi A, Cristoferi L, Carbone M, Asselta R, Invernizzi P (2018) The immunobiology of female predominance in primary biliary cholangitis. J Autoimmun 95:124\u2013132","journal-title":"J Autoimmun"},{"key":"8745_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaut.2018.02.007","volume":"90","author":"K Zhao","year":"2018","unstructured":"Zhao K, Du J, Peng Y, Li P, Wang S, Wang Y et al (2018) LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways. J Autoimmun 90:105\u2013115","journal-title":"J Autoimmun"},{"key":"8745_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaut.2018.01.003","volume":"90","author":"M Houtman","year":"2018","unstructured":"Houtman M, Shchetynsky K, Chemin K, Hensvold AH, Ramskold D, Tandre K et al (2018) T cells are influenced by a long non-coding RNA in the autoimmune associated PTPN2 locus. J Autoimmun 90:28\u201338","journal-title":"J Autoimmun"},{"key":"8745_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2018.04.004","volume":"92","author":"J Pieper","year":"2018","unstructured":"Pieper J, Dubnovitsky A, Gerstner C, James EA, Rieck M, Kozhukh G, Tandre K, Pellegrino S, Gebe JA, R\u00f6nnblom L, Sandalova T, Kwok WW, Klareskog L, Buckner JH, Achour A, Malmstr\u00f6m V (2018) Memory T cells specific to citrullinated alpha-enolase are enriched in the rheumatic joint. J Autoimmun 92:47\u201356","journal-title":"J Autoimmun"},{"key":"8745_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2018.11.003","volume":"98","author":"J Postigo-Fernandez","year":"2019","unstructured":"Postigo-Fernandez J, Creusot RJ (2019) A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in type 1 diabetes. J Autoimmun 98:13\u201323","journal-title":"J Autoimmun"},{"key":"8745_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaut.2018.09.013","volume":"96","author":"ML Ratliff","year":"2019","unstructured":"Ratliff ML, Garton J, Garman L, Barron MD, Georgescu C, White KA, Chakravarty E, Wren JD, Montgomery CG, James JA, Webb CF (2019) ARID3a gene profiles are strongly associated with human interferon alpha production. J Autoimmun 96:158\u2013167","journal-title":"J Autoimmun"},{"key":"8745_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jaut.2018.09.008","volume":"96","author":"AJ Svendsen","year":"2019","unstructured":"Svendsen AJ, Tan Q, Jakobsen MA, Thyagarajan B, Nygaard M, Christiansen L, Mengel-From J (2019) White blood cell mitochondrial DNA copy number is decreased in rheumatoid arthritis and linked with risk factors. A twin study. J Autoimmun 96:142\u2013146","journal-title":"J Autoimmun"},{"key":"8745_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.autrev.2018.02.002","volume":"17","author":"MF Bombini","year":"2018","unstructured":"Bombini MF, Peres FA, Lapa AT, Sinicato NA, Quental BR, Pincelli ASM et al (2018) Olfactory function in systemic lupus erythematosus and systemic sclerosis. A longitudinal study and review of the literature. Autoimmun Rev 17:405\u2013412","journal-title":"Autoimmun Rev"},{"key":"8745_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaut.2017.12.015","volume":"89","author":"E Chouri","year":"2018","unstructured":"Chouri E, Servaas NH, Bekker CPJ, Affandi AJ, Cossu M, Hillen MR, Angiolilli C, Mertens JS, van den Hoogen LL, Silva-Cardoso S, van der Kroef M, Vazirpanah N, Wichers CGK, Carvalheiro T, Blokland SLM, Giovannone B, Porretti L, Marut W, Vigone B, van Roon JAG, Beretta L, Rossato M, Radstake TRDJ (2018) Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis. J Autoimmun 89:162\u2013170","journal-title":"J Autoimmun"},{"key":"8745_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.autrev.2018.03.002","volume":"17","author":"J Claessens","year":"2018","unstructured":"Claessens J, Belmondo T, De Langhe E, Westhovens R, Poesen K, Hue S et al (2018) Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies. Autoimmun Rev 17:533\u2013540","journal-title":"Autoimmun Rev"},{"key":"8745_CR42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.autrev.2018.01.023","volume":"17","author":"M Cutolo","year":"2018","unstructured":"Cutolo M, Vanhaecke A, Ruaro B, Deschepper E, Ickinger C, Melsens K, Piette Y, Trombetta AC, de Keyser F, Smith V, EULAR Study Group on Microcirculation in Rheumatic Diseases (2018) Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients. Autoimmun Rev 17:775\u2013780","journal-title":"Autoimmun Rev"},{"key":"8745_CR43","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.autrev.2018.05.010","volume":"17","author":"R Dupont","year":"2018","unstructured":"Dupont R, Longue M, Galinier A, Cinq Frais C, Ingueneau C, Astudillo L et al (2018) Impact of micronutrient deficiency & malnutrition in systemic sclerosis: cohort study and literature review. Autoimmun Rev 17:1081\u20131089","journal-title":"Autoimmun Rev"},{"key":"8745_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.autrev.2018.01.006","volume":"17","author":"MJ Fritzler","year":"2018","unstructured":"Fritzler MJ, Hudson M, Choi MY, Mahler M, Wang M, Bentow C, Milo J, Baron M, Pope J, Baron M, Markland J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Hudson M, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larch\u00e9 M, Abu-Hakima M, Rodriguez-Reyna TS, Cabral AR, Fritzler MJ (2018) Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype. Autoimmun Rev 17:267\u2013275","journal-title":"Autoimmun Rev"},{"key":"8745_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.autrev.2018.11.001","volume":"18","author":"I Marie","year":"2019","unstructured":"Marie I (2019) Systemic sclerosis and exposure to heavy metals. Autoimmun Rev 18:62\u201372","journal-title":"Autoimmun Rev"},{"key":"8745_CR46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.autrev.2018.02.004","volume":"17","author":"G Martini","year":"2018","unstructured":"Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F (2018) Disease course and long-term outcome of juvenile localized scleroderma: experience from a single pediatric rheumatology centre and literature review. Autoimmun Rev 17:727\u2013734","journal-title":"Autoimmun Rev"},{"key":"8745_CR47","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.autrev.2018.06.009","volume":"17","author":"JPL Nunes","year":"2018","unstructured":"Nunes JPL, Cunha AC, Meirinhos T, Nunes A, Araujo PM, Godinho AR et al (2018) Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma - a review. Autoimmun Rev 17:1186\u20131201","journal-title":"Autoimmun Rev"},{"key":"8745_CR48","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.autrev.2018.02.008","volume":"17","author":"S Panopoulos","year":"2018","unstructured":"Panopoulos S, Bournia VK, Konstantonis G, Fragiadaki K, Sfikakis PP, Tektonidou MG (2018) Predictors of morbidity and mortality in early systemic sclerosis: long-term follow-up data from a single-centre inception cohort. Autoimmun Rev 17:816\u2013820","journal-title":"Autoimmun Rev"},{"key":"8745_CR49","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.autrev.2018.03.015","volume":"17","author":"I Sanz Perez","year":"2018","unstructured":"Sanz Perez I, Martinez Valle F, Guillen-Del-Castillo A, Roque Perez A, Cuellar Calabria H, Pizzi MN et al (2018) Subclinical cardiovascular disease and systemic sclerosis: a comparison between risk charts, quantification of coronary calcium and carotid ultrasonography. Autoimmun Rev 17:900\u2013905","journal-title":"Autoimmun Rev"},{"key":"8745_CR50","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.autrev.2018.01.012","volume":"17","author":"M Scherlinger","year":"2018","unstructured":"Scherlinger M, Guillotin V, Truchetet ME, Contin-Bordes C, Sisirak V, Duffau P, Lazaro E, Richez C, Blanco P (2018) Systemic lupus erythematosus and systemic sclerosis: all roads lead to platelets. Autoimmun Rev 17:625\u2013635","journal-title":"Autoimmun Rev"},{"key":"8745_CR51","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.4049\/jimmunol.1701542","volume":"200","author":"C Sun","year":"2018","unstructured":"Sun C, Chen SY (2018) RGC32 promotes bleomycin-induced systemic sclerosis in a murine disease model by modulating classically activated macrophage function. J Immunol 200:2777\u20132785","journal-title":"J Immunol"},{"key":"8745_CR52","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.autrev.2017.12.010","volume":"17","author":"M Thiebaut","year":"2018","unstructured":"Thiebaut M, Launay D, Riviere S, Mahevas T, Bellakhal S, Hachulla E et al (2018) Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review. Autoimmun Rev 17:582\u2013587","journal-title":"Autoimmun Rev"},{"key":"8745_CR53","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.autrev.2018.06.013","volume":"17","author":"X Yue","year":"2018","unstructured":"Yue X, Yu X, Petersen F, Riemekasten G (2018) Recent advances in mouse models for systemic sclerosis. Autoimmun Rev 17:1225\u20131234","journal-title":"Autoimmun Rev"},{"key":"8745_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.autrev.2018.09.002","volume":"18","author":"E Zanatta","year":"2019","unstructured":"Zanatta E, Famoso G, Boscain F, Montisci R, Pigatto E, Polito P, Schiavon F, Iliceto S, Cozzi F, Doria A, Tona F (2019) Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: a newsworthy association. Autoimmun Rev 18:177\u2013183","journal-title":"Autoimmun Rev"},{"key":"8745_CR55","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.autrev.2018.03.012","volume":"17","author":"E Zanatta","year":"2018","unstructured":"Zanatta E, Polito P, Favaro M, Larosa M, Marson P, Cozzi F, Doria A (2018) Therapy of scleroderma renal crisis: state of the art. Autoimmun Rev 17:882\u2013889","journal-title":"Autoimmun Rev"},{"key":"8745_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jaut.2018.02.001","volume":"91","author":"ILA Bodewes","year":"2018","unstructured":"Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm V et al (2018) TBK1: a key regulator and potential treatment target for interferon positive Sjogren\u2019s syndrome, systemic lupus erythematosus and systemic sclerosis. J Autoimmun 91:97\u2013102","journal-title":"J Autoimmun"},{"key":"8745_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4049\/jimmunol.1800357","volume":"202","author":"RM Clancy","year":"2019","unstructured":"Clancy RM, Halushka M, Rasmussen SE, Lhakhang T, Chang M, Buyon JP (2019) Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block. J Immunol 202:48\u201355","journal-title":"J Immunol"},{"key":"8745_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jaut.2018.10.019","volume":"97","author":"J Cortes","year":"2019","unstructured":"Cortes J, Hidalgo J, Aguilera S, Castro I, Brito M, Urra H et al (2019) Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjogren\u2019s syndrome patients. J Autoimmun 97:88\u201399","journal-title":"J Autoimmun"},{"key":"8745_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","volume":"18","author":"R Giacomelli","year":"2019","unstructured":"Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D\u2019Angelo S, de Vita S, di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG (2019) Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. Autoimmun Rev 18:93\u2013106","journal-title":"Autoimmun Rev"},{"key":"8745_CR60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.autrev.2018.08.007","volume":"18","author":"AV Goules","year":"2019","unstructured":"Goules AV, Tzioufas AG (2019) Lymphomagenesis in Sjogren\u2019s syndrome: predictive biomarkers towards precision medicine. Autoimmun Rev 18:137\u2013143","journal-title":"Autoimmun Rev"},{"key":"8745_CR61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaut.2018.02.005","volume":"90","author":"B Li","year":"2018","unstructured":"Li B, Wang F, Schall N, Muller S (2018) Rescue of autophagy and lysosome defects in salivary glands of MRL\/lpr mice by a therapeutic phosphopeptide. J Autoimmun 90:132\u2013145","journal-title":"J Autoimmun"},{"key":"8745_CR62","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2018.07.020","volume":"94","author":"E Liaskou","year":"2018","unstructured":"Liaskou E, Patel SR, Webb G, Bagkou Dimakou D, Akiror S, Krishna M, Mells G, Jones DE, Bowman SJ, Barone F, Fisher BA, Hirschfield GM (2018) Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-gamma secreting cells. J Autoimmun 94:143\u2013155","journal-title":"J Autoimmun"},{"key":"8745_CR63","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.autrev.2018.09.003","volume":"18","author":"E Martin-Nares","year":"2019","unstructured":"Martin-Nares E, Hernandez-Molina G (2019) Novel autoantibodies in Sjogren\u2019s syndrome: a comprehensive review. Autoimmun Rev 18:192\u2013198","journal-title":"Autoimmun Rev"},{"key":"8745_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.autrev.2018.06.015","volume":"18","author":"A Mirouse","year":"2019","unstructured":"Mirouse A, Seror R, Vicaut E, Mariette X, Dougados M, Fauchais AL, Deroux A, Dellal A, Costedoat-Chalumeau N, Denis G, Sellam J, Arlet JB, Lavigne C, Urbanski G, Fischer-Dumont D, Diallo A, Fain O, M\u00e9kinian A, Club Rhumatismes Inflammation and SNFMI (2019) Arthritis in primary Sjogren\u2019s syndrome: characteristics, outcome and treatment from French multicenter retrospective study. Autoimmun Rev 18:9\u201314","journal-title":"Autoimmun Rev"},{"key":"8745_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.11.002","volume":"98","author":"N Molano-Gonzalez","year":"2019","unstructured":"Molano-Gonzalez N, Rojas M, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Rodriguez Y et al (2019) Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity. J Autoimmun 98:24\u201332","journal-title":"J Autoimmun"},{"key":"8745_CR66","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.autrev.2018.02.003","volume":"17","author":"EP Navarro-Mendoza","year":"2018","unstructured":"Navarro-Mendoza EP, Aguirre-Valencia D, Posso-Osorio I, Correa-Forero SV, Torres-Cutiva DF, Loaiza D, Tob\u00f3n GJ (2018) Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sjogren\u2019s syndrome. Autoimmun Rev 17:709\u2013714","journal-title":"Autoimmun Rev"},{"key":"8745_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jaut.2018.02.010","volume":"91","author":"AG Vakrakou","year":"2018","unstructured":"Vakrakou AG, Boiu S, Ziakas PD, Xingi E, Boleti H, Manoussakis MN (2018) Systemic activation of NLRP3 inflammasome in patients with severe primary Sjogren\u2019s syndrome fueled by inflammagenic DNA accumulations. J Autoimmun 91:23\u201333","journal-title":"J Autoimmun"},{"key":"8745_CR68","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.autrev.2018.03.003","volume":"17","author":"EHM van der Heijden","year":"2018","unstructured":"van der Heijden EHM, Kruize AA, Radstake T, van Roon JAG (2018) Optimizing conventional DMARD therapy for Sjogren\u2019s syndrome. Autoimmun Rev 17:480\u2013492","journal-title":"Autoimmun Rev"},{"key":"8745_CR69","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.autrev.2018.08.008","volume":"18","author":"L Andreoli","year":"2019","unstructured":"Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D\u2019Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patan\u00e8 M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scir\u00e8 CA, Tincani A (2019) Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. Autoimmun Rev 18:164\u2013176","journal-title":"Autoimmun Rev"},{"key":"8745_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.autrev.2017.11.021","volume":"17","author":"L Barra","year":"2018","unstructured":"Barra L, Kanji T, Malette J, Pagnoux C, CanVasc (2018) Imaging modalities for the diagnosis and disease activity assessment of Takayasu\u2019s arteritis: a systematic review and meta-analysis. Autoimmun Rev 17:175\u2013187","journal-title":"Autoimmun Rev"},{"key":"8745_CR71","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.autrev.2018.01.019","volume":"17","author":"L Barra","year":"2018","unstructured":"Barra L, Yang G, Pagnoux C (2018) Non-glucocorticoid drugs for the treatment of Takayasu\u2019s arteritis: a systematic review and meta-analysis. Autoimmun Rev 17:683\u2013693","journal-title":"Autoimmun Rev"},{"key":"8745_CR72","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.autrev.2018.02.012","volume":"17","author":"F Berteau","year":"2018","unstructured":"Berteau F, Rouviere B, Delluc A, Nau A, Le Berre R, Sarrabay G et al (2018) Autosomic dominant familial Behcet disease and haploinsufficiency A20: a review of the literature. Autoimmun Rev 17:809\u2013815","journal-title":"Autoimmun Rev"},{"key":"8745_CR73","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.autrev.2018.07.005","volume":"17","author":"G Carvajal Alegria","year":"2018","unstructured":"Carvajal Alegria G, Groh M, Guellec D, Toussirot E, Rigaud J, Soubrier M, Ottaviani S, Direz G, Saraux A, Cornec D, CRI (Club Rhumatisme et inflammation) (2018) Anti-neutrophil cytoplasmic antibody-associated chronic inflammatory arthritis without vasculitis. Data from a French nationwide survey. Autoimmun Rev 17:1268\u20131269","journal-title":"Autoimmun Rev"},{"key":"8745_CR74","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.autrev.2018.01.016","volume":"17","author":"A Casian","year":"2018","unstructured":"Casian A, Sangle SR, D\u2019Cruz DP (2018) New use for an old treatment: hydroxychloroquine as a potential treatment for systemic vasculitis. Autoimmun Rev 17:660\u2013664","journal-title":"Autoimmun Rev"},{"key":"8745_CR75","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.autrev.2018.06.012","volume":"17","author":"T Chazal","year":"2018","unstructured":"Chazal T, Lhote R, Rey G, Haroche J, Eb M, Amoura Z, Cohen Aubart F (2018) Giant-cell arteritis-related mortality in France: a multiple-cause-of-death analysis. Autoimmun Rev 17:1219\u20131224","journal-title":"Autoimmun Rev"},{"key":"8745_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2017.11.029","volume":"17","author":"H de Boysson","year":"2018","unstructured":"de Boysson H, Daumas A, Vautier M, Parienti JJ, Liozon E, Lambert M, Samson M, Ebbo M, Dumont A, Sultan A, Bonnotte B, Manrique A, Bienvenu B, Saadoun D, Aouba A (2018) Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev 17:391\u2013398","journal-title":"Autoimmun Rev"},{"key":"8745_CR77","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.autrev.2017.11.026","volume":"17","author":"P Decker","year":"2018","unstructured":"Decker P, Olivier P, Risse J, Zuily S, Wahl D (2018) Tocilizumab and refractory Takayasu disease: four case reports and systematic review. Autoimmun Rev 17:353\u2013360","journal-title":"Autoimmun Rev"},{"key":"8745_CR78","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.autrev.2018.01.011","volume":"17","author":"A Dias-Santos","year":"2018","unstructured":"Dias-Santos A, Proenca RP, Tavares Ferreira J, Pinheiro S, Cunha JP, Proenca R et al (2018) The role of ophthalmic imaging in central nervous system degeneration in systemic lupus erythematosus. Autoimmun Rev 17:617\u2013624","journal-title":"Autoimmun Rev"},{"key":"8745_CR79","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2018.03.001","volume":"91","author":"S Gelb","year":"2018","unstructured":"Gelb S, Stock AD, Anzi S, Putterman C, Ben-Zvi A (2018) Mechanisms of neuropsychiatric lupus: the relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier. J Autoimmun 91:34\u201344","journal-title":"J Autoimmun"},{"key":"8745_CR80","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.autrev.2017.12.003","volume":"17","author":"R Goulabchand","year":"2018","unstructured":"Goulabchand R, Delicque J, Gallo M, Le Quellec A, Guilpain P (2018) Comment on the article entitled \u201cAntineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome\u201d (autoimmunity reviews 16 (2017) 1036-1043). Autoimmun Rev 17:431\u2013433","journal-title":"Autoimmun Rev"},{"key":"8745_CR81","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","volume":"17","author":"A Greco","year":"2018","unstructured":"Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G et al (2018) Behcet\u2019s disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev 17:567\u2013575","journal-title":"Autoimmun Rev"},{"key":"8745_CR82","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.autrev.2018.08.001","volume":"17","author":"M Iudici","year":"2018","unstructured":"Iudici M, Quartier P, Pagnoux C, Merlin E, Agard C, Aouba A, Roblot P, Cohen P, Terrier B, Mouthon L, Guillevin L, Pu\u00e9chal X, French Vasculitis Study Group (2018) Childhood- versus adult-onset polyarteritis nodosa results from the French Vasculitis Study Group Registry. Autoimmun Rev 17:984\u2013989","journal-title":"Autoimmun Rev"},{"key":"8745_CR83","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.autrev.2018.01.022","volume":"17","author":"S Jardel","year":"2018","unstructured":"Jardel S, Puechal X, Le Quellec A, Pagnoux C, Hamidou M, Maurier F et al (2018) Mortality in systemic necrotizing vasculitides: a retrospective analysis of the French Vasculitis Study Group registry. Autoimmun Rev 17:653\u2013659","journal-title":"Autoimmun Rev"},{"key":"8745_CR84","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.autrev.2018.02.006","volume":"17","author":"WF Jiemy","year":"2018","unstructured":"Jiemy WF, Heeringa P, Kamps J, van der Laken CJ, Slart R, Brouwer E (2018) Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of macrophages in large vessel vasculitis: current status and future prospects. Autoimmun Rev 17:715\u2013726","journal-title":"Autoimmun Rev"},{"key":"8745_CR85","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.autrev.2017.11.035","volume":"17","author":"MN Kolopp-Sarda","year":"2018","unstructured":"Kolopp-Sarda MN, Miossec P (2018) Cryoglobulins: an update on detection, mechanisms and clinical contribution. Autoimmun Rev 17:457\u2013464","journal-title":"Autoimmun Rev"},{"key":"8745_CR86","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.autrev.2018.01.024","volume":"17","author":"I Kone-Paut","year":"2018","unstructured":"Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M (2018) The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series. Autoimmun Rev 17:768\u2013774","journal-title":"Autoimmun Rev"},{"key":"8745_CR87","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.autrev.2017.11.024","volume":"17","author":"R Lopez-Mejias","year":"2018","unstructured":"Lopez-Mejias R, Castaneda S, Genre F, Remuzgo-Martinez S, Carmona FD, Llorca J et al (2018) Genetics of immunoglobulin-a vasculitis (Henoch-Schonlein purpura): an updated review. Autoimmun Rev 17:301\u2013315","journal-title":"Autoimmun Rev"},{"key":"8745_CR88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaut.2018.07.013","volume":"94","author":"A Maciejewski-Duval","year":"2018","unstructured":"Maciejewski-Duval A, Comarmond C, Leroyer A, Zaidan M, Le Joncour A, Desbois AC et al (2018) mTOR pathway activation in large vessel vasculitis. J Autoimmun 94:99\u2013109","journal-title":"J Autoimmun"},{"key":"8745_CR89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2018.04.002","volume":"91","author":"A Mekinian","year":"2018","unstructured":"Mekinian A, Resche-Rigon M, Comarmond C, Soriano A, Constans J, Alric L, Jego P, Busato F, Cabon M, Dhote R, Estibaliz L, Kon\u00e9-Paut I, Landron C, Lavigne C, Lioger B, Michaud M, Ruivard M, Sacre K, Gottenberg JE, Gaches F, Goulenok T, Salvarani C, Cacoub P, Fain O, Saadoun D (2018) Efficacy of tocilizumab in Takayasu arteritis: multicenter retrospective study of 46 patients. J Autoimmun 91:55\u201360","journal-title":"J Autoimmun"},{"key":"8745_CR90","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaut.2018.08.001","volume":"96","author":"A Mirouse","year":"2019","unstructured":"Mirouse A, Biard L, Comarmond C, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Cacoub P, Mirault T, Resche-Rigon M, Saadoun D, French Takayasu network (2019) Overall survival and mortality risk factors in Takayasu\u2019s arteritis: a multicenter study of 318 patients. J Autoimmun 96:35\u201339","journal-title":"J Autoimmun"},{"key":"8745_CR91","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jaut.2018.09.004","volume":"96","author":"M Mourguet","year":"2019","unstructured":"Mourguet M, Chauveau D, Faguer S, Ruidavets JB, Bejot Y, Ribes D et al (2019) Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitis. J Autoimmun 96:134\u2013141","journal-title":"J Autoimmun"},{"key":"8745_CR92","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.autrev.2018.07.012","volume":"18","author":"M Rinagel","year":"2019","unstructured":"Rinagel M, Chatelus E, Jousse-Joulin S, Sibilia J, Gottenberg JE, Chasset F, Arnaud L (2019) Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. Autoimmun Rev 18:56\u201361","journal-title":"Autoimmun Rev"},{"key":"8745_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaut.2018.10.001","volume":"97","author":"C Salvarani","year":"2019","unstructured":"Salvarani C, Brown RD Jr, Christianson TJH, Huston J 3rd, Morris JM, Giannini C et al (2019) Primary central nervous system vasculitis mimicking brain tumor: comprehensive analysis of 13 cases from a single institutional cohort of 191 cases. J Autoimmun 97:22\u201328","journal-title":"J Autoimmun"},{"key":"8745_CR94","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.autrev.2018.01.010","volume":"17","author":"M Tocut","year":"2018","unstructured":"Tocut M, Brenner R, Zandman-Goddard G (2018) Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors. Autoimmun Rev 17:610\u2013616","journal-title":"Autoimmun Rev"},{"key":"8745_CR95","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.autrev.2017.12.002","volume":"17","author":"A von Borstel","year":"2018","unstructured":"von Borstel A, Sanders JS, Rutgers A, Stegeman CA, Heeringa P, Abdulahad WH (2018) Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides. Autoimmun Rev 17:413\u2013421","journal-title":"Autoimmun Rev"},{"key":"8745_CR96","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.autrev.2018.06.003","volume":"17","author":"Y Yavne","year":"2018","unstructured":"Yavne Y, Tiosano S, Ben-Ami D, Watad A, Guy A, Comaneshter D, Cohen AD, Amital H (2018) Giant cell arteritis and inflammatory bowel disease - is there a connection? Results from a population-based study. Autoimmun Rev 17:1134\u20131137","journal-title":"Autoimmun Rev"},{"key":"8745_CR97","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.autrev.2017.11.027","volume":"17","author":"JF Augusto","year":"2018","unstructured":"Augusto JF, Truchetet ME, Charles N, Blanco P, Richez C (2018) IgE in lupus pathogenesis: friends or foes? Autoimmun Rev 17:361\u2013365","journal-title":"Autoimmun Rev"},{"key":"8745_CR98","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.autrev.2018.03.013","volume":"17","author":"C Dumestre-Perard","year":"2018","unstructured":"Dumestre-Perard C, Clavarino G, Colliard S, Cesbron JY, Thielens NM (2018) Antibodies targeting circulating protective molecules in lupus nephritis: interest as serological biomarkers. Autoimmun Rev 17:890\u2013899","journal-title":"Autoimmun Rev"},{"key":"8745_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.009","volume":"91","author":"MJ Lewis","year":"2018","unstructured":"Lewis MJ, McAndrew MB, Wheeler C, Workman N, Agashe P, Koopmann J et al (2018) Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus. J Autoimmun 91:1\u201312","journal-title":"J Autoimmun"},{"key":"8745_CR100","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.4049\/jimmunol.1700832","volume":"200","author":"RJ Stopforth","year":"2018","unstructured":"Stopforth RJ, Oldham RJ, Tutt AL, Duriez P, Chan HTC, Binkowski BF et al (2018) Detection of experimental and clinical immune complexes by measuring SHIP-1 recruitment to the inhibitory FcgammaRIIB. J Immunol 200:1937\u20131950","journal-title":"J Immunol"},{"key":"8745_CR101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2018.03.003","volume":"91","author":"T Kraaij","year":"2018","unstructured":"Kraaij T, Kamerling SWA, de Rooij ENM, van Daele PLA, Bredewold OW, Bakker JA, Bajema IM, Scherer HU, Toes REM, Huizinga TJW, Rabelink TJ, van Kooten C, Teng YKO (2018) The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus. J Autoimmun 91:45\u201354","journal-title":"J Autoimmun"},{"key":"8745_CR102","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.4049\/jimmunol.1700778","volume":"200","author":"N Gestermann","year":"2018","unstructured":"Gestermann N, Di Domizio J, Lande R, Demaria O, Frasca L, Feldmeyer L et al (2018) Netting neutrophils activate autoreactive B cells in lupus. J Immunol 200:3364\u20133371","journal-title":"J Immunol"},{"key":"8745_CR103","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.autrev.2018.03.016","volume":"17","author":"A Vaglio","year":"2018","unstructured":"Vaglio A, Grayson PC, Fenaroli P, Gianfreda D, Boccaletti V, Ghiggeri GM, Moroni G (2018) Drug-induced lupus: traditional and new concepts. Autoimmun Rev 17:912\u2013918","journal-title":"Autoimmun Rev"},{"key":"8745_CR104","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.autrev.2018.08.010","volume":"18","author":"A Goropevsek","year":"2019","unstructured":"Goropevsek A, Holcar M, Pahor A, Avcin T (2019) STAT signaling as a marker of SLE disease severity and implications for clinical therapy. Autoimmun Rev 18:144\u2013154","journal-title":"Autoimmun Rev"},{"key":"8745_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2018.06.014","volume":"18","author":"KH Lee","year":"2019","unstructured":"Lee KH, Lee H, Lee CH, Kim JY, Kim JM, Kim SS, Jeong S, Hwang IS, Kim N, Kim NE, Shin S, Shin D, Song JS, Shin DH, Kim JD, Kim J, Lee YS, Kang H, Kim DH, Moon SH, Rho WS, Lee JY, Kronbichler A, Shin JI (2019) Adrenal insufficiency in systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): a systematic review. Autoimmun Rev 18:1\u20138","journal-title":"Autoimmun Rev"},{"key":"8745_CR106","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41590-018-0107-1","volume":"19","author":"R Shinde","year":"2018","unstructured":"Shinde R, Hezaveh K, Halaby MJ, Kloetgen A, Chakravarthy A, da Silva Medina T, Deol R, Manion KP, Baglaenko Y, Eldh M, Lamorte S, Wallace D, Chodisetti SB, Ravishankar B, Liu H, Chaudhary K, Munn DH, Tsirigos A, Madaio M, Gabrielsson S, Touma Z, Wither J, de Carvalho DD, McGaha TL (2018) Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans. Nat Immunol 19:571\u2013582","journal-title":"Nat Immunol"},{"key":"8745_CR107","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.4049\/jimmunol.1700588","volume":"200","author":"A Suarez-Fueyo","year":"2018","unstructured":"Suarez-Fueyo A, Bradley SJ, Katsuyama T, Solomon S, Katsuyama E, Kyttaris VC et al (2018) Downregulation of CD3zeta in NK cells from systemic lupus erythematosus patients confers a proinflammatory phenotype. J Immunol 200:3077\u20133086","journal-title":"J Immunol"},{"key":"8745_CR108","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.autrev.2018.03.009","volume":"17","author":"DN Setoue","year":"2018","unstructured":"Setoue DN, Pitta AC, Fiorot FJ, Nastri MM, Novak GV, Molinari BC, Oliveira JC, Gormezano NW, Sakamoto AP, Terreri MT, Pereira RM, Saad-Magalh\u00e3es C, Sallum AM, Kozu K, Fraga MM, Piotto DP, Clemente G, Marini R, Gomes HR, Rabelo-Junior CN, Felix MM, Ribeiro MC, Almeida RG, Assad AP, Sacchetti SB, Barros LC, Bonf\u00e1 E, Silva CA (2018) Symptomatic polyautoimmunity at diagnosis of 1463 childhood-onset lupus: a Brazilian multicenter study. Autoimmun Rev 17:836\u2013839","journal-title":"Autoimmun Rev"},{"key":"8745_CR109","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41590-018-0102-6","volume":"19","author":"H Ryu","year":"2018","unstructured":"Ryu H, Lim H, Choi G, Park YJ, Cho M, Na H, Ahn CW, Kim YC, Kim WU, Lee SH, Chung Y (2018) Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27. Nat Immunol 19:583\u2013593","journal-title":"Nat Immunol"},{"key":"8745_CR110","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.autrev.2018.08.002","volume":"18","author":"M Adawi","year":"2019","unstructured":"Adawi M, Bragazzi NL, McGonagle D, Watad S, Mahroum N, Damiani G, Conic R, Bridgewood C, Mahagna H, Giacomelli L, Eggenh\u00f6ffner R, Mahamid M, Pigatto PDM, Amital H, Watad A (2019) Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: an evidence-informed and PRISMA compliant systematic review and meta-analysis. Autoimmun Rev 18:73\u201392","journal-title":"Autoimmun Rev"},{"key":"8745_CR111","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.autrev.2018.04.006","volume":"17","author":"M Garg","year":"2018","unstructured":"Garg M, Mufti N, Palmore TN, Hasni SA (2018) Recommendations and barriers to vaccination in systemic lupus erythematosus. Autoimmun Rev 17:990\u20131001","journal-title":"Autoimmun Rev"},{"key":"8745_CR112","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.autrev.2018.09.001","volume":"18","author":"M Garcia-Carrasco","year":"2019","unstructured":"Garcia-Carrasco M, Mendoza-Pinto C, Rojas-Villarraga A, Molano-Gonzalez N, Vallejo-Ruiz V, Munguia-Realpozo P et al (2019) Prevalence of cervical HPV infection in women with systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev 18:184\u2013191","journal-title":"Autoimmun Rev"},{"key":"8745_CR113","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.autrev.2018.02.011","volume":"17","author":"R Felten","year":"2018","unstructured":"Felten R, Dervovic E, Chasset F, Gottenberg JE, Sibilia J, Scher F, Arnaud L (2018) The 2018 pipeline of targeted therapies under clinical development for systemic lupus erythematosus: a systematic review of trials. Autoimmun Rev 17:781\u2013790","journal-title":"Autoimmun Rev"},{"key":"8745_CR114","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.autrev.2018.02.014","volume":"17","author":"X Dong","year":"2018","unstructured":"Dong X, Zheng Z, Zhai Y, Zheng Y, Ding J, Jiang J, Zhu P (2018) ACPA mediates the interplay between innate and adaptive immunity in rheumatoid arthritis. Autoimmun Rev 17:845\u2013853","journal-title":"Autoimmun Rev"},{"key":"8745_CR115","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.autrev.2018.04.004","volume":"17","author":"A Musaelyan","year":"2018","unstructured":"Musaelyan A, Lapin S, Nazarov V, Tkachenko O, Gilburd B, Mazing A, Mikhailova L, Shoenfeld Y (2018) Vimentin as antigenic target in autoimmunity: a comprehensive review. Autoimmun Rev 17:926\u2013934","journal-title":"Autoimmun Rev"},{"key":"8745_CR116","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.4049\/jimmunol.1701187","volume":"200","author":"EF McNaughton","year":"2018","unstructured":"McNaughton EF, Eustace AD, King S, Sessions RB, Kay A, Farris M et al (2018) Novel anti-inflammatory peptides based on chemokine-glycosaminoglycan interactions reduce leukocyte migration and disease severity in a model of rheumatoid arthritis. J Immunol 200:3201\u20133217","journal-title":"J Immunol"},{"key":"8745_CR117","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.4049\/jimmunol.1701756","volume":"200","author":"Q Zhong","year":"2018","unstructured":"Zhong Q, Gong FY, Gong Z, Hua SH, Zeng KQ, Gao XM (2018) IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in rheumatoid arthritis. J Immunol 200:3913\u20133925","journal-title":"J Immunol"},{"key":"8745_CR118","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.autrev.2018.06.006","volume":"17","author":"I Cecchi","year":"2018","unstructured":"Cecchi I, Arias de la Rosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N (2018) Neutrophils: novel key players in rheumatoid arthritis. Current and future therapeutic targets. Autoimmun Rev 17:1138\u20131149","journal-title":"Autoimmun Rev"},{"key":"8745_CR119","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.autrev.2018.01.003","volume":"17","author":"M Lidar","year":"2018","unstructured":"Lidar M, Giat E, Garelick D, Horowitz Y, Amital H, Steinberg-Silman Y, Schachter J, Shapira-Frommer R, Markel G (2018) Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors. Autoimmun Rev 17:284\u2013289","journal-title":"Autoimmun Rev"},{"key":"8745_CR120","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.autrev.2018.01.002","volume":"17","author":"MS Chimenti","year":"2018","unstructured":"Chimenti MS, Perricone C, Novelli L, Caso F, Costa L, Bogdanos D, Conigliaro P, Triggianese P, Ciccacci C, Borgiani P, Perricone R (2018) Interaction between microbiome and host genetics in psoriatic arthritis. Autoimmun Rev 17:276\u2013283","journal-title":"Autoimmun Rev"},{"key":"8745_CR121","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jaut.2018.08.008","volume":"96","author":"SM Wade","year":"2019","unstructured":"Wade SM, Trenkmann M, McGarry T, Canavan M, Marzaioli V, Wade SC, Veale DJ, Fearon U (2019) Altered expression of microRNA-23a in psoriatic arthritis modulates synovial fibroblast pro-inflammatory mechanisms via phosphodiesterase 4B. J Autoimmun 96:86\u201393","journal-title":"J Autoimmun"},{"key":"8745_CR122","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaut.2017.12.014","volume":"89","author":"A Jamin","year":"2018","unstructured":"Jamin A, Berthelot L, Couderc A, Chemouny JM, Boedec E, Dehoux L, Abbad L, Dossier C, Daugas E, Monteiro RC, Desch\u00eanes G (2018) Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice. J Autoimmun 89:149\u2013161","journal-title":"J Autoimmun"},{"key":"8745_CR123","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.4049\/jimmunol.1800122","volume":"200","author":"R Benitez","year":"2018","unstructured":"Benitez R, Delgado-Maroto V, Caro M, Forte-Lago I, Duran-Prado M, O\u2019Valle F et al (2018) Vasoactive intestinal peptide ameliorates acute myocarditis and atherosclerosis by regulating inflammatory and autoimmune responses. J Immunol 200:3697\u20133710","journal-title":"J Immunol"},{"key":"8745_CR124","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.autrev.2018.09.005","volume":"18","author":"M Scheinberg","year":"2019","unstructured":"Scheinberg M, Azevedo V (2019) The future landscape of biosimilars in rheumatology: where we are where we are going. Autoimmun Rev 18:203\u2013208","journal-title":"Autoimmun Rev"},{"key":"8745_CR125","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","volume":"17","author":"HH Shen","year":"2018","unstructured":"Shen HH, Yang YX, Meng X, Luo XY, Li XM, Shuai ZW, Ye DQ, Pan HF (2018) NLRP3: a promising therapeutic target for autoimmune diseases. Autoimmun Rev 17:694\u2013702","journal-title":"Autoimmun Rev"},{"key":"8745_CR126","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.autrev.2018.01.018","volume":"17","author":"MA Dragovich","year":"2018","unstructured":"Dragovich MA, Mor A (2018) The SLAM family receptors: potential therapeutic targets for inflammatory and autoimmune diseases. Autoimmun Rev 17:674\u2013682","journal-title":"Autoimmun Rev"},{"key":"8745_CR127","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.autrev.2018.01.026","volume":"17","author":"S Herbelet","year":"2018","unstructured":"Herbelet S, De Bleecker JL (2018) Immune checkpoint failures in inflammatory myopathies: an overview. Autoimmun Rev 17:746\u2013754","journal-title":"Autoimmun Rev"},{"key":"8745_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.10.025","volume":"97","author":"CS Curran","year":"2019","unstructured":"Curran CS, Gupta S, Sanz I, Sharon E (2019) PD-1 immunobiology in systemic lupus erythematosus. J Autoimmun 97:1\u20139","journal-title":"J Autoimmun"},{"key":"8745_CR129","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.autrev.2018.05.002","volume":"17","author":"J Narvaez","year":"2018","unstructured":"Narvaez J, Juarez-Lopez P, J LL, Narvaez JA, Palmero R, Garcia Del Muro X et al (2018) Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: fasciitis with myositis syndrome as a new complication of immunotherapy. Autoimmun Rev 17:1040\u20131045","journal-title":"Autoimmun Rev"},{"key":"8745_CR130","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jaut.2018.10.021","volume":"95","author":"S Piconese","year":"2018","unstructured":"Piconese S, Cammarata I, Barnaba V (2018) Viral hepatitis, inflammation, and cancer: a lesson for autoimmunity. J Autoimmun 95:58\u201368","journal-title":"J Autoimmun"},{"key":"8745_CR131","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.05.003","volume":"92","author":"YC Kim","year":"2018","unstructured":"Kim YC, Zhang AH, Yoon J, Culp WE, Lees JR, Wucherpfennig KW, Scott DW (2018) Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells. J Autoimmun 92:77\u201386","journal-title":"J Autoimmun"},{"key":"8745_CR132","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaut.2018.02.006","volume":"90","author":"S Koristka","year":"2018","unstructured":"Koristka S, Kegler A, Bergmann R, Arndt C, Feldmann A, Albert S, Cartellieri M, Ehninger A, Ehninger G, Middeke JM, Bornh\u00e4user M, Schmitz M, Pietzsch J, Akg\u00fcn K, Ziemssen T, Steinbach J, Bachmann MP (2018) Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology. J Autoimmun 90:116\u2013131","journal-title":"J Autoimmun"},{"key":"8745_CR133","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.08.007","volume":"95","author":"P Kumar","year":"2018","unstructured":"Kumar P, Bhattacharya P, Prabhakar BS (2018) A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity. J Autoimmun 95:77\u201399","journal-title":"J Autoimmun"},{"key":"8745_CR134","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2018.07.008","volume":"94","author":"C Sanchez-Blanco","year":"2018","unstructured":"Sanchez-Blanco C, Clarke F, Cornish GH, Depoil D, Thompson SJ, Dai X, Rawlings DJ, Dustin ML, Zamoyska R, Cope AP, Purvis HA (2018) Protein tyrosine phosphatase PTPN22 regulates LFA-1 dependent Th1 responses. J Autoimmun 94:45\u201355","journal-title":"J Autoimmun"},{"key":"8745_CR135","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.autrev.2018.07.001","volume":"17","author":"G Montes Diaz","year":"2018","unstructured":"Montes Diaz G, Hupperts R, Fraussen J, Somers V (2018) Dimethyl fumarate treatment in multiple sclerosis: recent advances in clinical and immunological studies. Autoimmun Rev 17:1240\u20131250","journal-title":"Autoimmun Rev"},{"key":"8745_CR136","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.autrev.2017.12.004","volume":"17","author":"M Consuegra-Fernandez","year":"2018","unstructured":"Consuegra-Fernandez M, Lin F, Fox DA, Lozano F (2018) Clinical and experimental evidence for targeting CD6 in immune-based disorders. Autoimmun Rev 17:493\u2013503","journal-title":"Autoimmun Rev"},{"key":"8745_CR137","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.autrev.2018.05.007","volume":"17","author":"K Sharif","year":"2018","unstructured":"Sharif K, Amital H, Shoenfeld Y (2018) The role of dietary sodium in autoimmune diseases: the salty truth. Autoimmun Rev 17:1069\u20131073","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-019-08745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-019-08745-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-019-08745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:49:27Z","timestamp":1694933367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-019-08745-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":137,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["8745"],"URL":"https:\/\/doi.org\/10.1007\/s12016-019-08745-w","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"5 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No ethical approval for the local IRB was needed for this review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Informed Consent"}}]}}